Epidermal growth factor and hepatocyte growth factor cooperate to enhance cell proliferation, scatter, and invasion in murine mammary epithelial cells
Open Access
- 22 October 2009
- journal article
- Published by Bioscientifica in Journal of Molecular Endocrinology
- Vol. 44 (2) , 115-125
Abstract
The development of the mammary gland requires an integrated response to specific growth factors and steroid hormones. Hepatocyte growth factor (HGF) and its tyrosine kinase receptor, MET, are expressed and temporally regulated during mammary development and differentiation. Epidermal growth factor receptor (EGFR) and its ligands have also been implicated in mammary gland growth and morphogenesis. Since both cytokines seem to exert a morphogenic program in this tissue, we have investigated the possible concerted action of EGF and HGF on the HC11 cell line, a widely used model of nontumorigenic mammary cells. Western blot analysis indicated that HC11 expressed MET and EGFR, and showed ERK1/2 and AKT activation following HGF or EGF treatment. Analysis by real-time PCR and western blot showed that after an EGF but not HGF or insulin-like growth factor-I treatment, HC11 mammary cells exhibited an increase in MET expression at both the mRNA and protein levels, which was dependent on the AKT pathway. Simultaneous treatment with HGF and EGF increased proliferation, scatter, and invasion as assessed by cell count, cell cycle, scatter, and transwell assays. AKT inhibition did not influence the cooperation on proliferation or invasion after HGF+EGF treatment, while ERK1/2 inhibition abolished MET/EGFR cooperation on proliferation. HGF+EGF treatment increased the duration of ERK1/2 and AKT activation compared to HGF or EGF alone. All these data indicate that a crosstalk between the EGF and HGF pathways in mammary epithelial cells may modulate the development of the mammary gland.Keywords
This publication has 15 references indexed in Scilit:
- An In vivo Model of Met-Driven Lymphoma as a Tool to Explore the Therapeutic Potential of Met InhibitorsClinical Cancer Research, 2008
- Signaling networks assembled by oncogenic EGFR and c-MetProceedings of the National Academy of Sciences, 2008
- The MET receptor tyrosine kinase in invasion and metastasisJournal of Cellular Physiology, 2007
- Amphiregulin is an essential mediator of estrogen receptor α function in mammary gland developmentProceedings of the National Academy of Sciences, 2007
- Met, metastasis, motility and moreNature Reviews Molecular Cell Biology, 2003
- Regulation of mammary gland branching morphogenesis by the extracellular matrix and its remodeling enzymesBreast Cancer Research, 2003
- Epidermal Growth Factor Receptor Signaling Activates Met in Human Anaplastic Thyroid Carcinoma CellsExperimental Cell Research, 2000
- Essential function of Wnt-4 in mammary gland development downstream of progesterone signalingGenes & Development, 2000
- IGF-I: An Essential Factor in Terminal End Bud Formation and Ductal MorphogenesisJournal of Mammary Gland Biology and Neoplasia, 2000
- A mutation in the epidermal growth factor receptor in waved-2 mice has a profound effect on receptor biochemistry that results in impaired lactation.Proceedings of the National Academy of Sciences, 1995